Raymond James Maintains Strong Buy on Tenet Healthcare, Raises Price Target to $95
Portfolio Pulse from richadhand@benzinga.com
Raymond James analyst John Ransom maintains a Strong Buy rating on Tenet Healthcare (NYSE:THC) and raises the price target from $85 to $95.
August 04, 2023 | 10:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James maintains a Strong Buy rating on Tenet Healthcare and raises the price target from $85 to $95.
The news of Raymond James maintaining a Strong Buy rating and raising the price target for Tenet Healthcare is likely to instill confidence in investors and could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100